iM3 Catalogue - Europe - Flipbook - Page 82
ORALVIVE
®
Physical barrier gel for topical application to teeth and gums
Cat. Code
GSP001A
OralVive® is a 0.8% hyaluronic acid gel formulation (pH 6.5–7.5), supplied as 3 mL of gel in a
3 mL pre-filled capped Luer-lock syringe with four separate applicator tips per pack.
Hyaluronic acid (HA) is a naturally occurring biomaterial that has been proven safe and effective in both humans and dogs for
a variety of indications, including dentistry.
Dental applications of HA have shown statistically
significant efficacy in 5+ canine studies and 100+ human
studies.
OralVive® consists of a pre-filled tissue applicator
containing HA for convenient and precise delivery to
tissues.
1 syringe + 4 spare tips for application are included.
Simple to use.
OralVive® contains fewer synthetic agents and no
dyes, making it gentle on sensitive oral tissues.
Results (3 months)
2
Absolute change (mm or mm)
Restoration relative to defect (%)
m
(m
gr
ow
th
Establishing microbial barrier to support tissue
healing and recovery
n
ow
ll
ld
nt
a
ith
el
ia
do
Baseline
10 weeks
Control
Tella et al., 2023
AUTHOR AND YEAR
INDICATION
Tella et al., 2023
Class II furcations
Shirakata et al., 2022
Class III furcations
Shirakata et al., 2021
Gingival recessions
Shirakata et al., 2021
Two-wall intrabony defects
Kim et al., 2016
Infected extraction sockets
Coronally
Advanced
Flap
Coronally
Advanced
Flap
+
Hyaluronic
Acid
All studies conducted via split-mouth design (i.e. self-control)
Page 76
2 weeks
Ep
Pe
rio
)
)
m
m
(m
en
t(
ig
am
um
en
t
em
rc
la
lu
Ac
el
HA only
m
m2
)
)
m
ne
Bo
Bo
ne
he
ig
ar
ea
ht
(m
(m
m
th
gr
ow
n
ow
ld
el
ia
Ep
ith
HA / ADMA
)
Stabilising blood clotting
(m
(m
en
t
am
lig
al
Supporting normal cellular in昀椀ltration
)
)
m
m
(m
um
en
t
do
nt
io
Pe
r
Ac
el
lu
la
rc
em
Bo
ne
ar
ea
(m
(m
m
)
m2
)
)
100
90
80
70
60
50
40
30
20
10
0
he
ig
ht
ne
Bo
CO N S U M A B L E S
10
9
8
7
6
5
4
3
2
1
0
Hyaluronic acid works to improve tissue recovery
via multiple mechanisms of action, including:
www.im3vet.eu
Shirakata et al., 2021
